Skip to main content
OpenTrials

Clinical trial condition

Refractory Pancreatic Neuroendocrine Carcinoma

Explore clinical trials studying Refractory Pancreatic Neuroendocrine Carcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Refractory Pancreatic Neuroendocrine Carcinoma trial results

Completed

Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery

NCT02893930

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Islet Cell, +18 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • CHI Saint Vincent Cancer Center Hot Springs Hot Springs, Arkansas, United States
  • PCR Oncology Arroyo Grande, California, United States
View all 405 locations
View Trial Details

Related conditions